Summary
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Metabolic and endocrine contexts, while Hexarelin is more of a hormone peptide and Sermorelin is better described as a hormone peptide. Both appear to work through Receptor agonist, which is one of the main reasons they can look related despite other differences. Hexarelin has a more synthetic design origin, while Sermorelin is closer to synthetic analog background and their development context also differs, with Hexarelin in Preclinical development while Sermorelin is approved. Their sequence patterns also diverge, with Hexarelin showing protein-mimetic sequence features and Sermorelin showing alpha-helical domain features.